SCM

Superstring Capital Management Portfolio holdings

AUM $187M
1-Year Est. Return 270.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+270.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
+$85.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$13.7M
2
+$6.85M
3
+$5.79M
4
DFTX
Definium Therapeutics
DFTX
+$5.26M
5
AXSM icon
Axsome Therapeutics
AXSM
+$5.23M

Top Sells

1
+$7.99M
2
+$5.65M
3
+$5.39M
4
BBIO icon
BridgeBio Pharma
BBIO
+$4.6M
5
SMMT icon
Summit Therapeutics
SMMT
+$4.08M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDTX
1
DELISTED
Cidara Therapeutics
CDTX
$18.8M 10.06%
85,098
+16,635
TERN icon
2
Terns Pharmaceuticals
TERN
$4.57B
$17.9M 9.6%
443,777
-345,869
URGN icon
3
UroGen Pharma
URGN
$890M
$16.8M 9.01%
718,354
+630,442
COGT icon
4
Cogent Biosciences
COGT
$6.31B
$13M 6.96%
366,238
+4,830
DVAX
5
DELISTED
Dynavax Technologies
DVAX
$8.08M 4.33%
+525,592
SION
6
Sionna Therapeutics
SION
$1.51B
$7.43M 3.98%
+180,593
IMVT icon
7
Immunovant
IMVT
$5.65B
$7.34M 3.93%
288,677
-52,671
AXSM icon
8
Axsome Therapeutics
AXSM
$8.51B
$6.84M 3.66%
+37,433
SVRA icon
9
Savara
SVRA
$1.22B
$6M 3.21%
995,353
-313,883
DFTX
10
Definium Therapeutics
DFTX
$1.69B
$5.69M 3.05%
+425,202
TSHA icon
11
Taysha Gene Therapies
TSHA
$1.24B
$5.39M 2.89%
+980,768
OCUL icon
12
Ocular Therapeutix
OCUL
$2.39B
$5.08M 2.72%
+418,080
FOLD icon
13
Amicus Therapeutics
FOLD
$4.5B
$5.03M 2.69%
+352,896
CABA icon
14
Cabaletta Bio
CABA
$318M
$4.94M 2.64%
2,253,550
+709,025
UTHR icon
15
United Therapeutics
UTHR
$22.1B
$4.61M 2.47%
+9,451
RVMD icon
16
Revolution Medicines
RVMD
$19.6B
$4.37M 2.34%
+54,879
BLTE
17
Belite Bio
BLTE
$6.66B
$3.95M 2.12%
+24,703
DRUG
18
Bright Minds Biosciences
DRUG
$810M
$3.69M 1.98%
47,278
-6,672
ZLAB icon
19
Zai Lab
ZLAB
$2.06B
$3.47M 1.86%
196,853
-3,775
ZBIO
20
Zenas BioPharma
ZBIO
$1.37B
$3.03M 1.62%
83,353
-13,312
QNCX icon
21
Quince Therapeutics
QNCX
$5.5M
$2.88M 1.54%
+858,711
AVTX icon
22
Avalo Therapeutics
AVTX
$333M
$2.78M 1.49%
153,313
-34,767
CAPR icon
23
Capricor Therapeutics
CAPR
$1.46B
$2.78M 1.49%
+96,334
PVLA
24
Palvella Therapeutics
PVLA
$1.57B
$2.67M 1.43%
+25,469
CLDX icon
25
Celldex Therapeutics
CLDX
$1.99B
$2.4M 1.28%
+88,308
1
2 3